Citizens' Issues
Chemical bombing kills 650 in Syria

Anti-regime activists from Syria alleged that the army had used chemical arms in its bombardment on the densely-populated Ghouta suburbs killing 650 people

More than 650 people were killed when Syrian army used chemical weapons for bombardment in suburbs of Damascus on Wednesday. The Opposition has branded it a 'massacre' and called for international intervention.

 

According to activists, hundreds of people died of gas inhalation and exposure to chemical weapons.

 

Syrian authorities, however, had denied charges that the army used chemical arms. “Reports on the use of chemical weapons in (the suburbs of) Ghouta are totally false,” state news agency SANA said adding, “It’s an attempt to prevent the UN commission of inquiry from carrying out its mission.”

 

Britain, meanwhile, said it would refer the alleged chemical weapons attack, which could not immediately be verified and has been vehemently denied by the Damascus regime to the United Nations (UN).

 

While the Syrian National Coalition gave a toll of 650 dead, a Britain-based monitoring group said earlier that at least 100 people had been killed and the number was rising.

 

“This figure will surely go up. The raids and bombardment are continuing,” said the Syrian Observatory for Human Rights, which gathers its information from activists and medics.

 

It did not comment on allegations by anti-regime activists that the army had used chemical arms in its bombardment of the densely-populated Ghouta suburbs where rebels have been holding out against Government forces.

User

Rupee ends at 64.02 against US dollar; breaches 101 level against pound

The British pound has become the first major foreign currency to cost more than 100 rupees apiece

The Indian rupee closed Wednesday at 64.02 against the US dollar, while breaching the 101 lever against the British pound as foreign investors continued to unwind their investments from the stock markets.

 

After opening at 63.45, the domestic currency moved in a range of 64.53-63.15 intra-day before closing at 64.02 against the US dollar. The rupee had closed at 63.23 on Tuesday.

 

Losing its ground further, the Indian currency also hit a new low against the British pound and breached the 101-level in the afternoon trade.

 

After crossing the 100-level for the first time ever against the British pound in intra-day trade yesterday, the rupee had managed to close marginally below this mark at 99.04 against the pound.

 

However, it slipped further to as low as 101.20 this afternoon at the Interbank Foreign Exchange (Forex) market.

 

The rupee has depreciated by around 22% against the British pound over the past three months from close to 83 level in mid-May. It was at about 80 in March.

 

The pound has become the first major foreign currency to cost more than 100 apiece. It is the most expensive against the Indian rupee among major foreign currencies, followed by the euro, Swiss franc, US dollar, Canadian dollar, Australian dollar, New Zealand dollar and Singapore dollar.

User

COMMENTS

Abhijit Gosavi

3 years ago

Judging by what you can buy (due to the inflation) with a rupee in India, according to many ground sources, a fair poverty line in India is about Rs 100/day. If you compare that to the dollar, where the poverty line is set at $1.25 per day, the rupee should go to $1.25 = Rs. 100, i.e., $1 = Rs. 80. #rupee

Bajaj Allianz Life refunds Rs30,000: Another Moneylife Helpline success

Bajaj Allianz Life sold ULIP to a consumer without obtaining his signature on the sales illustration, as mandated by IRDA. Moneylife intervention helped to solve a difficult case that even insurance ombudsman had refused to take up. Bajaj Allianz generously agreed to a settlement of Rs30,000

An agent of Bajaj Allianz Life had sold Capital Unit Gain ULIP to a consumer without obtaining his signature on the sales illustration, as is directed by Insurance Regulatory and Development Authority (IRDA). The policyholder paid three premiums and then surrendered the policy. After finding about the IRDA directive, he raised the issue on technical grounds. Even though the policyholder filed complaint at an advanced stage, Moneylife intervention helped to solve a difficult case with kind consideration of Bajaj Allianz Life who were generous to pay Rs30,000 to the policyholder. It was an intricate case that was refused to be taken up by the insurance ombudsman of Hyderabad.


Moneylife Foundation Insurance Helpline received following email from Chirag Rao (name changed).

 

I had bought Bajaj Allianz Capital Unit Gain ULIP on 14 Sep 2007. My annual premium was Rs75,000 and I paid it for three years and surrendered the policy on 13 Sep 2010. The amount I received after surrendering the policy was approximately Rs2.01 lakh. I later came to know that IRDA had directed Bajaj Allianz Life to withdraw the product within 15 days from the date the directive was issued i.e. 13 Aug 2007 as the product was not customer friendly. Bajaj Allianz sought an extension of period for selling the policy. IRDA gave them an extension till 15 Sep 2007 to sell the policy with the condition that the policy must be accompanied by sales illustration signed by the policy buyer.

 

Mr Sam Ghosh, then managing director of Bajaj Allianz in his interview to Economic Times in Sep 2007 said that further sale of Capital Unit Gain ULIP will be done only if the policy buyers signed the sales illustration. http://articles.economictimes.indiatimes.com/2007-09-03/news/28468876_1_mis-selling-ulips-actuarial-funded  IRDA in its directive had also mentioned that it will conduct inspections in the future to verify if signatures have been obtained on sales illustration. In reply to my RTI application to IRDA asking them if any inspection had been done to verify the same, I received a reply that the information was not available.

 

I initially registered a complaint with IRDA IGMS (Integrated Grievance Management System) # 04-13-020634 and 05-13-011717. Bajaj Allianz have accepted in their reply to my complaint that there has been a procedural lapse on their part, but also contended that this would not amount to mis-selling. If the sales illustration had been shown to me I would have had second thoughts on buying the policy in question. I also complained to the office of the insurance ombudsman, Hyderabad. I received a reply that my complaint does not come under their purview and that I may contact IRDA, which had issued the directive.

 

Is Mr Rao case an aberration or many policyholders suffered due to Bajaj Allianz purported “procedural lapse”? Sep 2007 Economic Times interview has Mr Ghosh stating, “We will print lakhs of forms and distribute them to our agents. If an agent does not bring in a signed copy of the illustration along with the proposal, we will ask him to go back and get one.” Clearly, it was not done in the case of Mr Rao. It proves that Bajaj Allianz did not comply with what it’s then managing director told media.

 

Bajaj Allianz had not given any indication of accepting Mr Rao’s request. Moreover, why does IRDA’s reply to the RTI reveal that there is no information with IRDA itself on them conducting inspections? Moneylife took the issue with IRDA. Bajaj Allianz changed their stand with reply to Moneylife stating, “We are in talks with customer. As agreed by him and on his explicit consent, we have initiated the process of settlement.” Bajaj Allianz Life refunded Mr Rao an amount of Rs30000 within four days.

 

Before Moneylife intervention, Bajaj Allianz Life had refused to budge with policyholder request. It is evident from their email response to the policyholder grievance, which states, “Any grievance as regards mis-selling cannot be entertained by the company at this belated stage after you have already enjoyed insurance cover and surrendered the policy in accordance with the terms and conditions as contained in the contract of insurance. In fact payment of renewal premium without protest is sufficient to indicate your ratification of the terms and conditions of the insurance policy. You have not been able to indicate how you have been prejudiced on account of the procedural lapse in not obtaining your signatures on the sales illustration in the year 2007 and the reason for raising such grievance after the policy is already surrendered.”

 

Benefit illustrations of many old ULIPs were mis-leading. Thus, taking signature of customer on flawed benefit illustration may not mean much. Agents would present deceptive benefit illustration, sanctioned by the Regulator to seal the deal. Moneylife had written about how one customer relied on the misleading benefit illustration of HDFC Life Young Star product that conveniently ignored the steep mortality charges, which made up for 80% of the premium for one policy.

 

Read HDFC Life child plan sold to senior citizen erodes 96% of investment amount!

 

Is Reliance Life’s corporate agent AB Capital involved in fraudulent “interest-free loan” offers? Will Reliance or the regulators initiate action?

 

New India Assurance pays Rs34,313 for mediclaim initially rejected: Another Moneylife success

 

PNB Metlife refunds Rs25,000 to the correct policyholder: another Moneylife victory

 

HDFC Life shares medical reports of online term plan after Moneylife request

User

COMMENTS

Mohanraj

3 years ago

I have also purchased the same policy from Bajaj, and I was not aware of any sale illustration document. So its possible to file a case against Bajaj Allianz.

Mohanraj
8939567814

P M Ravindran

3 years ago

Kudos ML!In fact the Insurance Ombudsman seems to be another useless office created to provide post retirement sinecures for officials who were helpful out of the way to the decision makers. The other day I was reading a report of a consumer 'court' providing a relief denied by the IO! Recently, I too had a bad experience with the IO, Kochi. It involved the New India Assurance Co and their mediclaim policy. A cancer patient was provided oral chemotherapy as an outpatient and the claim was denied on that ground alone when Clause 3.4 of the Mediclaim Policy (2007) issued by The NIACL explicitly stated that a claim was admissible for‘...any other surgeries/procedures agreed to by the TPA/COMPANY which require less than 24 hospitalisation due to advancement in Medical Technology‘. Now 'agreed to by the TPA/Company' cannot be interpreted to be used in favour of policy holders who are employees of the insurance company or their kith and kin only. But the Ombudsman felt it was perfectly ok to interpret it that way!

sunil

3 years ago

whether we can force hdfc life to do the same?

PREMNATH N KINI

3 years ago

Congratulations !!!
We look forward to reading of many more of such achivements.

DR HASNAIN PATEL

3 years ago

We bought a policy with Aviva where we were told that we had to pay in 2 lac pr year for 5 years and then not withdraw funds for another 5 year lock in and we coould then withdraw as needed and get insurance of 1 crore.

After 3 years we were informed it is a life policy payable every year for 25 years, My wife is 61 years old. This policy should never have been sold.

We then wanted to opt out and from a payment of 6 lac we were paid about 2.5 lac.

WHAT A LOOT BY BIRLA AVIVA

nagesh kini

3 years ago

Another feather in the cap for MLF! Keep it up.
Whether public or private sector both are equally guilty and need to be pulled up and only no partisan agencies are qualified to discharge this vital function.

nagesh kini

3 years ago

Another feather in the cap for MLF! Keep it up.
Whether public or private sector both are equally guilty and need to be pulled up and only no partisan agencies are qualified to discharge this vital function.

N Kanitkar

3 years ago

Mr Pradhan, congratulations and keep up the good work. In today's dog eat dog world, Moneylife stands out and does a wonderfully honest job.

REPLY

raj

In Reply to N Kanitkar 3 years ago

thanks

We are listening!

Solve the equation and enter in the Captcha field.
  Loading...
Close

To continue


Please
Sign Up or Sign In
with

Email
Close

To continue


Please
Sign Up or Sign In
with

Email

BUY NOW

The Scam
24 Year Of The Scam: The Perennial Bestseller, reads like a Thriller!
Moneylife Magazine
Fiercely independent and pro-consumer information on personal finance
Stockletters in 3 Flavours
Outstanding research that beats mutual funds year after year
MAS: Complete Online Financial Advisory
(Includes Moneylife Magazine and Lion Stockletter)